Le Lézard
Classified in: Health
Subjects: PET, ANW, MRR

Animal Parasiticides Market is Anticipated to Reach USD 15.6 billion, at a CAGR of 5.7% CAGR by 2031 - Report by Transparency Market Research Inc.


Implementation of seasonal awareness campaigns encourages timely parasite control, impacting market dynamics positively.

WILMINGTON, Del., Dec. 12, 2023 /PRNewswire/ -- The global animal parasiticides market is estimated to flourish at a CAGR of 5.7% from 2023 to 2031. According to Transparency Market Research, sales of animal parasiticides are slated to total US$ 15.6 billion by the end of the aforementioned period of assessment.

Transparency Market Research Logo

Evolving regulations on livestock and pet care drive the market. Stricter compliance measures and guidelines for parasite control spur the development of new formulations and treatment approaches. Increasing recognition of the interconnection between human, animal, and environmental health prompts a collaborative "One Health" approach. This drives the demand for parasiticides to prevent zoonotic diseases, benefiting animals and humans.

Request Sample Copy of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=10841

Animal Parasiticides Market Report Scope:

Report Coverage

Details 

Forecast Period

2023-2031

Base Year

2022

Size in 2022

US$ 9.4 Bn

Forecast (Value) in 2031

US$ 15.6 Bn

Growth Rate (CAGR)

5.7 %

No. of Pages

281

Segments covered

Product, Species

 

Expansion into untapped markets in developing regions presents opportunities. Growing urbanization, rising disposable income, and improved awareness about animal health amplify the demand for effective parasiticides.

Advancements in understanding animal microbiomes shape new strategies for parasite control. Harnessing microbiome knowledge leads to innovative approaches like probiotics and microbiota-based parasiticides for preventive care. Exploration of novel delivery systems, such as transdermal patches or wearable technology for sustained release, enhances convenience and compliance, revolutionizing parasite treatment methodologies.

Key Findings of the Market Report

Animal Parasiticides Market Growth Drivers & Trends

Ask Expert for the Research Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=ASK&rep_id=10841

Global Animal Parasiticides Market: Regional Profile

Animal Parasiticides Market: Competitive Landscape

The animal parasiticides market highlights a competitive landscape driven by leading players like Zoetis, Bayer AG, and Boehringer Ingelheim. These key industry giants dominate with diverse portfolios of innovative parasiticides, from spot-ons and oral formulations to collars and injectables.

Intensified research in developing regions has empowered local players like Ceva Santé Animale and Elanco, fostering competition. Collaborations for novel formulations and acquisitions to expand product offerings characterize the market.

Evolving consumer demand for sustainable, effective, and safe parasiticides propels continuous innovation, driving competitiveness among established and emerging players in the global animal health sector. Some prominent manufacturers are as follows:

Product Portfolio

Animal Parasiticides Market: Key Segments

By Product

By Species

By Region

Contact us for Special Discount and Pricing: https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=10841 

More Trending Reports by Transparency Market Research ?

Acute Lymphoblastic Leukemia Market- The global acute lymphoblastic leukemia market is anticipated to reach more than US$ 4.5 Bn by the end of 2031 and The global market is projected to grow at a CAGR of 7.6% from 2022 to 2031

Homeopathic Products Market- The global homeopathy products market is anticipated to reach more than US$ 32.4 Bn by the end of 2031 and the global market is projected to advance at a CAGR of 11.6% from 2022 to 2031

Synthetic Biology Market- The global market is anticipated to reach more than US$ 74.7 Bn by the end of 2031 and the global market is projected to advance at a CAGR of 21.3% from 2022 to 2031

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact:

Nikhil Sawlani
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA ? Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com   
Blog: https://tmrblog.com   
Email: [email protected]

Logo: https://mma.prnewswire.com/media/1682871/TMR_Logo_Logo.jpg

 


These press releases may also interest you

at 05:05
Sun Nuclear, a Mirion Medical company, will feature new and enhanced solutions for better Quality Management at the ESTRO Annual Meeting, May 3-6, in Glasgow, Scotland. The Sun Nuclear booth (#930) will highlight demonstrations and insights on the...

at 04:32
According to the latest BCC...

at 03:05
In Q1 2024, LEO Pharma delivered a revenue growth of 13% in constant exchange rates (CER). The dermatology portfolio saw accelerated growth in revenue of 16%. The acquisition of TMB-001 to the treatment of congenital ichthyosis added a late-stage...

at 02:22
Hansa Biopharma AB (publ), ("Hansa" or the "Company") (STO: HNSA) today announced that the company's registered share capital and number of shares and votes have increased through the issue of 10,474,740 new ordinary shares on 12 April 2024, whereby...

at 02:20
Vicore Pharma Holding (STO:VICO) Stockholm, May 3 2024- Vicore Pharma Holding AB (STO:VICO) ("Vicore"), unlocking the potential of a new class of drug candidates, angiotensin II type 2 receptor agonists (ATRAGs), publishes the interim...

2 mai 2024
The report titled "Muscle Stimulator Market by Technique (Burst Mode Alternating Current, Functional Electrical Stimulation, Interferential), Modality (Handheld, Portable, Table Top), Area, Application, End-User - Global Forecast 2024-2030" is now...



News published on and distributed by: